Multilaboratory Comparison of <i>Streptococcus pneumoniae</i> Opsonophagocytic Killing Assays and Their Level of Agreement for the Determination of Functional Antibody Activity in Human Reference Sera

Charles E. Rose(Centers for Disease Control and Prevention), Sandra Romero‐Steiner(Centers for Disease Control and Prevention), Robert L. Burton(Centers for Disease Control and Prevention), George M. Carlone(Centers for Disease Control and Prevention), David Goldblatt(Centers for Disease Control and Prevention), Moon H. Nahm(Centers for Disease Control and Prevention), Lindsey Ashton(Centers for Disease Control and Prevention), Mitch Haston(Centers for Disease Control and Prevention), Nina Ekström(Centers for Disease Control and Prevention), Raili Haikala(Centers for Disease Control and Prevention), Helena Käyhty(Centers for Disease Control and Prevention), Isabelle Henckaerts(Centers for Disease Control and Prevention), Nathalie Durant(Centers for Disease Control and Prevention), Jan Poolman(Centers for Disease Control and Prevention), Phil Fernsten(Centers for Disease Control and Prevention), Xinhong Yu(Centers for Disease Control and Prevention), Branda Hu(Centers for Disease Control and Prevention), Kathrin U. Jansen(Centers for Disease Control and Prevention), Milan S. Blake(Centers for Disease Control and Prevention), Elles Simonetti(Centers for Disease Control and Prevention), Peter W. M. Hermans(Centers for Disease Control and Prevention), Brian D. Plikaytis(Centers for Disease Control and Prevention)
Clinical and Vaccine Immunology
November 18, 2010
Cited by 66Open Access
Full Text

Abstract

Antibody-mediated killing of Streptococcus pneumoniae (pneumococcus) by phagocytes is an important mechanism of protection of the human host against pneumococcal infections. Measurement of opsonophagocytic antibodies by use of a standardized opsonophagocytic assay (OPA) is important for the evaluation of candidate vaccines and required for the licensure of new pneumococcal conjugate vaccine formulations. We assessed agreement among six laboratories that used their own optimized OPAs on a panel of 16 human reference sera for 13 pneumococcal serotypes. Consensus titers, estimated using an analysis-of-variance (ANOVA) mixed-effects model, provided a common reference for assessing agreement among these laboratories. Agreement was evaluated in terms of assay accuracy, reproducibility, repeatability, precision, and bias. We also reviewed four acceptance criterion intervals for assessing the comparability of protocols when assaying the same reference sera. The precision, accuracy, and concordance results among laboratories and the consensus titers revealed acceptable agreement. The results of this study indicate that the bioassays evaluated in this study are robust, and the resultant OPA values are reproducible for the determination of functional antibody titers specific to 13 pneumococcal serotypes when performed by laboratories using highly standardized but not identical assays. The statistical methodologies employed in this study may serve as a template for evaluating future multilaboratory studies.


Related Papers

No related papers found

Powered by citation graph analysis